RDM
Red Metal Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 1.65%
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
3
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Red Metal Ltd. engages in the acquisition and exploration of mineral prospects. The company is headquartered in Sydney, New South Wales. The company went IPO on 2003-10-27. The principal activities of the Company are acquisition and exploration of mineral prospects in Australia. The firm's projects include Yarrie copper-cobalt and copper-gold project, Gulf copper-gold project and Lawn Hill Project. Its funded projects include Gidyea copper-gold project, Corkwood Copper-Gold project, Three Ways Project, Pardoo Nickel-Copper and Gold project, Punt Hill and Pernatty Lagoon Copper-Gold project, Nullarbor Project, and Callabonna Copper-Gold project. The firm's other projects are located in the regions, including Queensland, Western Australia, South Australia and Northern Territory. The Corkwood project is situated about 100 kilometers northwest of Glencore’s Ernest Henry copper-gold mine and about 60 kilometers north of the Little Eva copper-gold deposit.
📈 Performance
Price History
+138.39%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.10
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in RDM
3
📊 Total Capital Earnings
$2K
🔃 Average investment frequency
19 weeks
💵 Average investment amount
$1,613
⏰ Last time a customer invested in RDM
44 days
RDM investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
33%
50k - 100k
67%
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
33%
Male
67%
Pearlers who invest in RDM also invest in...
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
6.82%
📊 Share price
$68.56 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
20.56%
📊 Share price
$61.40 AUD
📈 HIGH PRICE GROWTH
💰 HIGH DIVIDEND
🇺🇸 UNITED STATES
VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
🙌 Performance (5Yr p.a)
19.76%
📊 Share price
$452.54 AUD
🤖 TECHNOLOGY
🇺🇸 UNITED STATES
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
16.12%
📊 Share price
$139.00 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.
🙌 Performance (5Yr p.a)
-7.06%
📊 Share price
$0.02 AUD
🧬 BIOTECHNOLOGY
Want more shares? Try these...
